1,597 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 680 increasing their positions, 576 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% more funds holding

Funds holding: 1,5381,597 (+59)

1.05% more ownership

Funds ownership: 78.09%79.15% (+1.1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,597
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
79
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$7.72B
2 +$2.26B
3 +$592M
4
Barclays
Barclays
United Kingdom
+$248M
5
Goldman Sachs
Goldman Sachs
New York
+$164M

Top Sellers

1 -$1.36B
2 -$392M
3 -$151M
4
Primecap Management
Primecap Management
California
-$148M
5
O
OrbiMed
New York
-$148M
Name Holding Trade Value Shares
Change
Change in
Stake
1301
$389K
1302
$389K
1303
$385K
1304
$385K
1305
$382K
1306
$382K
1307
$382K
1308
$379K
1309
$377K
1310
$374K
1311
$373K
1312
$371K
1313
$371K
1314
$370K
1315
$369K
1316
$369K
1317
$367K
1318
$365K
1319
$365K
1320
$361K
1321
$358K
1322
$358K
1323
$358K
1324
$357K
1325
$356K